Sunosi approval date?

When was Sunosi (solriamfetol) approved by the FDA?

Sunosi was approved by the U.S. Food and Drug Administration (FDA) on February 22, 2019 for the treatment of excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea (OSA). [1]

What was Sunosi’s first FDA label for?

In its original FDA approval, Sunosi was indicated for excessive daytime sleepiness in adults with either narcolepsy or obstructive sleep apnea. [1]

Where can I verify the approval date?

You can verify FDA approval history through DrugPatentWatch.com’s drug page for Sunosi. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/sunosi/